全文获取类型
收费全文 | 2225篇 |
免费 | 141篇 |
国内免费 | 3篇 |
专业分类
2369篇 |
出版年
2022年 | 9篇 |
2021年 | 14篇 |
2020年 | 14篇 |
2019年 | 15篇 |
2018年 | 27篇 |
2017年 | 27篇 |
2016年 | 50篇 |
2015年 | 48篇 |
2014年 | 71篇 |
2013年 | 114篇 |
2012年 | 99篇 |
2011年 | 96篇 |
2010年 | 66篇 |
2009年 | 72篇 |
2008年 | 120篇 |
2007年 | 109篇 |
2006年 | 119篇 |
2005年 | 125篇 |
2004年 | 137篇 |
2003年 | 102篇 |
2002年 | 120篇 |
2001年 | 96篇 |
2000年 | 82篇 |
1999年 | 67篇 |
1998年 | 23篇 |
1997年 | 24篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 11篇 |
1993年 | 27篇 |
1992年 | 62篇 |
1991年 | 36篇 |
1990年 | 31篇 |
1989年 | 29篇 |
1988年 | 27篇 |
1987年 | 26篇 |
1986年 | 30篇 |
1985年 | 30篇 |
1984年 | 19篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 13篇 |
1980年 | 12篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1976年 | 10篇 |
1975年 | 12篇 |
1974年 | 12篇 |
1972年 | 10篇 |
1968年 | 10篇 |
排序方式: 共有2369条查询结果,搜索用时 0 毫秒
1.
2.
Masayo Suzuki Hiroyuki Ishida Yukimasa Shiotsu Taisuke Nakata Shiro Akinaga Shigemitsu Takashima Toshiaki Utsumi Toshiaki Saeki Nobuhiro Harada 《The Journal of steroid biochemistry and molecular biology》2009,113(3-5):195-201
In order to evaluate the importance of estrogen production in tumor and surrounding tissues, we measured mRNA expression levels of 5 enzymes participating to estrogen synthesis in situ and 4 breast cancer-related proteins in 27 pairs of tumor and non-malignant tissues. Steroid sulfatase (STS) mRNA was more frequently detected in tumor tissues rather than in their non-malignant counterparts. Estrogen sulfotransferase (EST) was constantly expressed with high level not only in tumor tissues but also in their surrounding non-malignant counterparts. In contrast, mRNA expression levels of aromatase, and 17β-hydroxysteroid dehydrogenase type I and II were relatively low and detected only in small proportion of the patients. We also measured the mRNA expression levels of the same nine genes in tumor tissues of 197 breast cancer patients, and analyzed relationship between the mRNA expression level and the clinicopathological parameters. The mRNA expression levels of STS, aromatase and erbB2 in tumor tissues increased as breast cancer progressed. The tumoral mRNA expression levels of STS, estrogen receptor β, and erbB2 in patients with recurrence were higher than those in patients without recurrence. Upregulation of STS expression plays an important role in tumor progression of human breast cancer and is considered to be responsible for estrogen production in tumor and surrounding tissues. 相似文献
3.
Structural studies of a human gamma 3 myeloma protein (Jir) bearing the allotypic marker Gm(st) 总被引:2,自引:0,他引:2
H Matsumoto S Ito T Miyazaki T Ohta 《Journal of immunology (Baltimore, Md. : 1950)》1983,131(4):1865-1870
The authors established the amino acid substitutions determining G3m(s) and G3m(t) specificities, which characterize Mongoloid populations, by sequence analysis of the Fc region of a myeloma protein (Jir). By comparing the amino acid sequences of the IgG3 (Jir) and the other IgG subclasses analyzed to date, it was found that G3m(s) was an isoallotype specified by an amino acid substitution at position 435; i.e., whereas the subclasses IgG1, IgG2, and IgG4 had histidine in common, G3m(s-) had arginine in this position. This was also confirmed by the observation that the Fc fragment in question bound to protein A. It was also established that the amino acid at position 379 of G3m(t-) IgG3 and the other subclasses was valine, whereas methionine in this position was specific for G3m(t+). In addition, the amino acids at position 339 of G3m(u-) IgG3 Jir was threonine, and at position 296 of G3m(g-) IgG3 Jir was tyrosine. These findings are not in accord with the hitherto postulated relations of alanine and phenylalanine to G3m(u-) and G3m(g-), respectively. Finally, this study showed that a large number of substitutions occurred at positions 384 through 389, which suggests that many specificities of the G3m(b) group occur on IgG3 proteins. 相似文献
4.
5.
K Miyazaki F Umenishi K Funahashi N Koshikawa H Yasumitsu M Umeda 《Biochemical and biophysical research communications》1992,185(3):852-859
Progelatinase A was purified as a complex with TIMP-2 from the conditioned medium of a human glioblastoma cell line. The TIMP-2/progelatinase complex was resistant to the activation by p-aminophenylmercuric acetic acid (APMA), and showed less than 10% of the activity of the TIMP-2-free active enzyme. When the complex was incubated with stromelysin in the presence of APMA, the 64-kDa progelatinase was effectively converted to the 57-kDa mature enzyme, increasing its gelatinolytic activity about 8-fold. These results suggest that stromelysin is a natural activator of TIMP-2-bound progelatinase A. 相似文献
6.
BACKGROUND: We report a successful pregnancy in a woman with severe ovarian dysfunction and infertility associated with a variant beta-subunit of luteinizing hormone (LH). METHOD/OUTCOME: A 35-year-old woman consulted our unit for infertility. Laparoscopy and ultrasonography showed obstruction of the right tube and ovulation from the right ovary only. Human menopausal gonadotrophin (hMG) therapy was used for six subsequent cycles, but did not result in conception. Subsequently, marked elevation of follicle-stimulating hormone (FSH) and testosterone, together with polycystic ovary (PCO) were noted. The patient failed to respond to ovarian stimulation by hMG. Severe ovarian dysfunction such as premature ovarian failure (POF) was strongly suspected. Sequence analysis of the LH beta-subunit gene indicated heterozygosity for point mutations Trp(8) to Arg(8) and Ile(15) to Thr(15) in the coding sequence. LH hypersecretion resembling that seen in PCO syndrome was observed. Induction of ovulation by hMG was successful in the first cycle in which the basal LH and FSH were well controlled with gonadotrophin-releasing hormone analog following estrogen-progesterone replacement. She conceived and delivered a healthy male infant at term. CONCLUSION: Clinicians should be clinically aware of patients with immunologically anomalous LH variant who might be at risk of developing ovarian failure within a relatively short time span. Pertinent treatment should be applied without delay in such cases. 相似文献
7.
8.
9.
F Suzuki S Miyazaki M Uozumi N Okamoto S Yamashita K Murakami Y Nakamura 《FEBS letters》1989,256(1-2):47-50
The release of prorenin as well as renin from rat renal slices was confirmed by a rat prorenin-prosegment ELISA system and an assay system for determining the renin activity. A significant increase of the prorenin release was found by adding rat submandibular gland extract to the slice medium, indicating the existence of a prorenin-releasing stimulator (PRS) in the extract. The pI and molecular mass of PRS were 8.5-8.7 and 28-30 kDa, respectively. The PRS was completely inactivated by boiling or a proteinase treatment. 相似文献
10.
H Miyazaki T Fujii H Amejima N Mikuriya K Nambu A Kagemoto M Nakao Y Oh-e K Matsumoto Y Matsui 《Biotherapy》1988,1(1):7-18
Disposition of [125I]rHu-TNF was elucidated in BALB/c mice bearing Meth A fibrosarcoma 7 days after transplantation. After i.v. administration, [125I]rHu-TNF measured by radioactivity and immunoreactivity biphasically decreased in plasma. Tumor level of [125I]rHu-TNF was the maximum at 1 h, then decreased and finally remained essentially constant. After i.t. administration, plasma level reached the maximum at 1 h. Tumor level decreased quickly and then became essentially constant. [125I]rHu-TNF was suggested to be degraded to small fragments in the tumor. Significant distribution of [125I]rHu-TNF was found in the kidney, lung, liver and tumor. Most tissue levels decreased with time in parallel with plasma levels. [125I]rHu-TNF radioactivity was found in proximal convoluted tubules of kidney and in those areas of tumor consisting of degenerating cells with pyknotic nuclei. Urine contained most of administered radioactivity, which being neither immunoreactive nor protein-bound. 相似文献